New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

About 23% of MRI scans of the hand or wrist may reveal an incidental finding, and only about 3% overall may need further ...

A UK study shows that ADHD in young women increased during the COVID-19 pandemic, peaking in the age group 20-24 years; ...

The brain’s map of the body remains largely unaffected by amputation, potentially informing phantom limb pain management and ...

A phase 3 trial suggests reducing the use of cisplatin when treating nasopharyngeal carcinoma with toripalimab-based ...

Children with IBD and concomitant primary sclerosing cholangitis have substantially worse outcomes, with elevated risks for ...

A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing ...

The American College of Obstetricians and Gynecologists (ACOG) has issued new guidelines on deferred umbilical cord clamping ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

In nine studies (76 patients), the anti-IgE monoclonal antibody omalizumab (Xolair), given every 2-4 weeks at doses ranging ...

The FDA has approved brensocatib tablets in 10-mg and 25-mg doses as once-daily treatment for non-cystic fibrosis ...